{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T22:24:33Z","timestamp":1788560673620,"version":"build-2803163510"},"reference-count":47,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T00:00:00Z","timestamp":1548806400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T00:00:00Z","timestamp":1548806400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Addiction"],"published-print":{"date-parts":[[2019,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context and Purpose<\/jats:title>\n                    <jats:p>Measurement\u2010based care (MBC) is an evidence\u2010based health\u2010care practice in which indicators of disease are tracked to inform clinical actions, provide feedback to patients and improve outcomes. The current opioid crisis in multiple countries provides a pressing rationale for adopting a basic MBC approach for opioid use disorder (OUD) using DSM\u20105 to increase treatment retention and effectiveness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Proposal<\/jats:title>\n                    <jats:p>To stimulate debate, we propose a basic MBC approach using the 11 symptoms of OUD (DSM\u20105) to inform the delivery of medications for opioid use disorder (MOUD; including methadone, buprenorphine and naltrexone) and their evaluation in office\u2010based primary care and specialist clinics. Key features of a basic MBC approach for OUD using DSM\u20105 are described, with an illustration of how clinical actions are guided and outcomes communicated. For core treatment tasks, we propose that craving and drug use response to MOUD should be assessed after 2\u00a0weeks, and OUD remission status should be evaluated at 3, 6 and 12\u00a0months (and exit from MOUD treatment) and beyond. Each of the 11 DSM\u20105 symptoms of OUD should be discussed with the patient to develop a case formulation and guide selection of adjunctive psychological interventions, supplemented with information on substance use, and optionally extended with information from other clinical instruments. A patient\u2010reported outcome measure should be recorded and discussed at each remission assessment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>MBC can be used to tailor and adapt MOUD treatment to increase engagement, retention and effectiveness. MBC practice principles can help promote patient\u2010centred care in OUD, personalized addiction therapeutics and facilitate communication of outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/add.14546","type":"journal-article","created":{"date-parts":[[2019,1,6]],"date-time":"2019-01-06T21:33:27Z","timestamp":1546810407000},"page":"1346-1353","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["Measurement\u2010based care using DSM\u20105 for opioid use disorder: can we make opioid medication treatment more effective?"],"prefix":"10.1111","volume":"114","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1307-2498","authenticated-orcid":false,"given":"John","family":"Marsden","sequence":"first","affiliation":[{"name":"Addictions Department Institute of Psychiatry, Psychology and Neuroscience, King's College London  UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betty","family":"Tai","sequence":"additional","affiliation":[{"name":"National Institute on Drug Abuse, National Institutes of Health  Rockville MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Ali","sequence":"additional","affiliation":[{"name":"Discipline of Pharmacology, School of Medicine The University of Adelaide  South Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"Hu","sequence":"additional","affiliation":[{"name":"National Institute on Drug Abuse, National Institutes of Health  Rockville MD USA"},{"name":"The Emmes Corporation  Rockville MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. John","family":"Rush","sequence":"additional","affiliation":[{"name":"Duke\u2010National University of Singapore  Singapore"},{"name":"Department of Psychiatry Duke University Medical School  Durham USA"},{"name":"Department of Psychiatry Texas Tech Health Sciences Center  TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Volkow","sequence":"additional","affiliation":[{"name":"National Institute on Drug Abuse, National Institutes of Health  Rockville MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,1,30]]},"reference":[{"key":"e_1_2_4_2_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596"},{"key":"e_1_2_4_3_1","unstructured":"HedegaardH WarnerM MininoAM.Drug overdose deaths in the United States 1999\u20132016. CHS Data Brief no. 294. Hyattsville MD: National Center for Health Statistics 2017; Centers for Disease Control and Prevention. National Vital Statistics System Mortality; CDC Wonder Atlanta GA: US Department of Health and Human Services CDC 2017."},{"key":"e_1_2_4_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1800216"},{"key":"e_1_2_4_5_1","unstructured":"Penington Institute.Australia's annual overdose report 2017. Available at:http:\/\/www.penington.org.au\/australias\u2010annual\u2010overdose\u2010report\u20102017(accessed 7 December 2018) (Archived athttp:\/\/www.webcitation.org\/75XTomrdDon 19 January 2019)."},{"key":"e_1_2_4_6_1","volume-title":"European Drug Report 2017: Trends and Developments","author":"European Monitoring Centre for Drugs and Drug Addiction","year":"2017"},{"key":"e_1_2_4_7_1","doi-asserted-by":"publisher","DOI":"10.7326\/M16-2149"},{"key":"e_1_2_4_8_1","unstructured":"National Institutes of Health.News Releases. NIH launches HEAL Initiative doubles funding to accelerate scientific solutions to stem national opioid epidemic. Available at:https:\/\/www.nih.gov\/news\u2010events\/news\u2010releases\/nih\u2010launches\u2010heal\u2010initiative\u2010doubles\u2010funding\u2010accelerate\u2010scientific\u2010solutions\u2010stem\u2010national\u2010opioid\u2010epidemic(accessed 17 December 2018)."},{"key":"e_1_2_4_9_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1497.2001.016009606.x"},{"key":"e_1_2_4_10_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.2006.163.11.1905"},{"key":"e_1_2_4_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/biom.12493"},{"key":"e_1_2_4_12_1","first-page":"1","article-title":"Practice guideline for the treatment of patients with major depressive disorder (revision)","volume":"157","author":"American Psychiatric Association","year":"2000","journal-title":"Am J Psychiatry"},{"key":"e_1_2_4_13_1","unstructured":"National Institute for Health and Care Excellence (NICE).Depression in adults: recognition and management. Clinical guideline CG90.London:NICE;2009."},{"key":"e_1_2_4_14_1","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","volume":"2","author":"Mattick R. P.","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_4_15_1","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","volume":"2","author":"Mattick R. P.","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_4_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2007.01.014"},{"key":"e_1_2_4_17_1","doi-asserted-by":"publisher","DOI":"10.7326\/M17-3107"},{"key":"e_1_2_4_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.13193"},{"key":"e_1_2_4_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e5945"},{"key":"e_1_2_4_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.14059"},{"key":"e_1_2_4_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60358-9"},{"key":"e_1_2_4_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32812-X"},{"key":"e_1_2_4_23_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2017.3206"},{"key":"e_1_2_4_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1497.2005.0228.x"},{"key":"e_1_2_4_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.12333"},{"key":"e_1_2_4_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2004.09.006"},{"key":"e_1_2_4_27_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.14m09096"},{"key":"e_1_2_4_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61420-3"},{"key":"e_1_2_4_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2018.03.052"},{"key":"e_1_2_4_30_1","article-title":"Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence","volume":"10","author":"Amato L.","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_4_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0740-5472(01)00199-4"},{"key":"e_1_2_4_32_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2004.10400045"},{"key":"e_1_2_4_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2012.03971.x"},{"key":"e_1_2_4_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2005.01012.x"},{"key":"e_1_2_4_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2011.03464.x"},{"key":"e_1_2_4_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2012.07.013"},{"key":"e_1_2_4_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2008.02284.x"},{"key":"e_1_2_4_38_1","doi-asserted-by":"publisher","DOI":"10.1017\/S2045796017000622"},{"key":"e_1_2_4_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2011.09.005"},{"key":"e_1_2_4_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2014.03.018"},{"key":"e_1_2_4_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2004.06.001"},{"key":"e_1_2_4_42_1","volume-title":"The Case Formulation Approach to Cognitive\u2010Behavior Therapy","author":"Persons J. B.","year":"2008"},{"key":"e_1_2_4_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.12472"},{"key":"e_1_2_4_44_1","unstructured":"National Institute on Alcohol Abuse and Alcoholism (NIAAA).NIAAA council approves definition of binge drinking [online].2004. US Department of Health and Human Services National Institute on Alcohol Abuse and Alcoholism (NIAAA). Available at:http:\/\/pubs.niaaa.nih.gov\/publications\/Newsletter\/winter2004\/Newsletter_Number3.pdf(accessed 17 December 2018)."},{"key":"e_1_2_4_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2005.08.010"},{"key":"e_1_2_4_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2016.06.006"},{"key":"e_1_2_4_47_1","doi-asserted-by":"publisher","DOI":"10.1159\/000484239"},{"key":"e_1_2_4_48_1","doi-asserted-by":"publisher","DOI":"10.1370\/afm.1139"}],"container-title":["Addiction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fadd.14546","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/add.14546","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/add.14546","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/add.14546","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T05:35:16Z","timestamp":1780983316000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/add.14546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,30]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["10.1111\/add.14546"],"URL":"https:\/\/doi.org\/10.1111\/add.14546","archive":["Portico"],"relation":{},"ISSN":["0965-2140","1360-0443"],"issn-type":[{"value":"0965-2140","type":"print"},{"value":"1360-0443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,30]]},"assertion":[{"value":"2018-10-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-12-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}